News & Press: Patient Safety

FDA Recommends a Trial Stimulation Period Before Implanting a Spinal Cord Stimulator (SCS)

Tuesday, September 8, 2020  

On September 3, 2020, the U.S. Food and Drug Administration (FDA) reminded health care providers of the importance of conducting a trial stimulation period to allow patients to confirm satisfactory pain relief before implanting a spinal cord stimulator (SCS).

The FDA reminder covers important information about SCS, including:

  • Recommendations for health care providers to consider before SCS implantation.
  • Recommended topics for patient-doctor communication.
  • Actions the FDA has taken to evaluate information included in SCS medical device reports.
  • Instructions for reporting problems with a SCS device.

Click here for more information.

Contact Us

120 E. Ogden Ave. Ste. 202
Hinsdale, Illinois 60521
P: 630.203.2252
Toll Free: 888.255.0005

© Copyright 2019 Spine Intervention Society 501(c)( 3) Privacy Policy  ::  Legal